Alerislife Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2022 to a ratio of 14.36, above the company average. This is a clear sign of healthy business climate in the Healthcare Facilities industry and improving liquidity at their respective customers, during the third quarter 2022. Average receivable collection period, for the Alerislife Inc in Sep 30 2022 quarter, has decreased to 25 days, compared to 63 days, in the Jun 30 2022 quarter.

If we take a look into Healthcare sector 13 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 266, from overall ranking in the second quarter 2022 at 867.

What is Receivable Turnover Ratio?
What is Alerislife Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ALR Receivables Turnover Ratio	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter
Y / Y Receivable Change	-85.05 %	-87.01 %	-88.22 %	-90.25 %	-11.53 %
Y / Y Revenue Change	-19.12 %	-33.83 %	-35.66 %	-36.34 %	-23.53 %
Receivable Turnover Ratio (TTM)	14.36	5.79	3.92	3.06	2.58
ALR's Total Ranking	# 266	# 867	# 265	# 863	# 265
Accounts Receivable average collection period days	25	63	93	119	141
Seq. Receivable Change	12.17 %	3.39 %	16.93 %	-88.98 %	-2.51 %
Seq. Revenue Change	6.74 %	-1.17 %	-4.36 %	-19.83 %	-12.68 %

Receivable Turnover Company Ranking
Within:	No.
Healthcare Facilities Industry	# 4
Healthcare Sector	# 14
Overall Market	# 266

Receivable Turnover Ratio Statistics
High	Average	Low
1.83	0.46	0.22
(Sep 30 2022)		(Dec 31 2021)

ALR Company Profile • Back to ALR Efficiency Comparisons • Compare ALR Receivables Turnover Ratio to its Competitors

Financial Statements
Alerislife Inc 's Accounts Receivable	$ 56 Millions	Visit ALR's Balance sheet
Alerislife Inc 's Sales TTM	$ 708 Millions	Visit ALR's Income Statement
Sources of ALR's Revenues		Visit ALR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ALR's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ALR's Growth Rates	ALR's Roa	ALR's Inventory Turnover Ratio	ALR's Dividend Comparisons
ALR's Profitability Ratios	ALR's Roi	ALR's Asset Turnover Ratio	ALR's Dividend Growth
ALR's Valuation Ratios	ALR's Roe	ALR's Financial Strength Ratios	ALR's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2022	Receivable at quarter ending Sep 30 2022
National Vision Holdings Inc	32.81	$ 2,014.324 Millions	$ 61.385 Millions
Electromedical Technologies Inc	31.17	$ 0.963 Millions	$ 0.031 Millions
Notable Labs Ltd	30.83	$ 1.426 Millions	$ 0.046 Millions
Sqz Biotechnologies Company	29.18	$ 21.886 Millions	$ 0.750 Millions
Voyager Therapeutics Inc	28.21	$ 70.531 Millions	$ 2.500 Millions
Albireo Pharma inc	27.25	$ 57.391 Millions	$ 2.106 Millions
Arbutus Biopharma Corp	26.09	$ 35.980 Millions	$ 1.379 Millions
Vireo Growth Inc.	25.49	$ 69.239 Millions	$ 2.717 Millions
Immunogen inc	25.22	$ 95.607 Millions	$ 3.792 Millions
Inmed Pharmaceuticals Inc	25.18	$ 1.410 Millions	$ 0.056 Millions
Ainos Inc	25.07	$ 2.508 Millions	$ 0.100 Millions
U S Physical Therapy Inc	23.69	$ 428.977 Millions	$ 18.111 Millions
Catalyst Pharmaceuticals Inc	21.25	$ 191.755 Millions	$ 9.024 Millions
Talkspace Inc	21.05	$ 145.655 Millions	$ 6.920 Millions
Nutriband Inc	20.57	$ 2.044 Millions	$ 0.099 Millions
Anika Therapeutics Inc	20.43	$ 152.435 Millions	$ 7.461 Millions
Wearable Health Solutions, Inc.	20.27	$ 0.960 Millions	$ 0.047 Millions
U s Stem Cell Inc	20.17	$ 0.086 Millions	$ 0.004 Millions
Biomerica Inc	19.29	$ 19.247 Millions	$ 0.998 Millions
Intellia Therapeutics Inc	19.20	$ 51.402 Millions	$ 2.677 Millions
Lftd Partners Inc	19.07	$ 58.890 Millions	$ 3.087 Millions
Vystar Corporation	18.33	$ 15.105 Millions	$ 0.824 Millions
Arcturus Therapeutics Holdings Inc	18.15	$ 51.500 Millions	$ 2.837 Millions
C4 Therapeutics Inc	18.09	$ 48.320 Millions	$ 2.672 Millions
Statera Biopharma Inc fka Cytocom Inc	18.01	$ 3.688 Millions	$ 0.205 Millions
Sangamo Therapeutics Inc	17.93	$ 112.055 Millions	$ 6.248 Millions
Zomedica Corp	17.70	$ 12.688 Millions	$ 0.717 Millions
Theralink Technologies Inc	17.62	$ 0.568 Millions	$ 0.032 Millions
Ainos Inc	17.57	$ 1.758 Millions	$ 0.100 Millions
Innovage Holding Corp	17.37	$ 696.788 Millions	$ 40.123 Millions

Date modified: 2026-08-29T17:19:32+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.